Rituximab in the treatment of shrinking lung syndrome in systemic lupus erythematosus

Patricia Peñacoba Toribio, María Emilia Córica Albani, Mercedes Mayos Pérez, Arturo Rodríguez de la Serna

Research output: Contribution to journalArticleResearchpeer-review

12 Citations (Scopus)

Abstract

Shrinking lung syndrome (SLS) is a rare manifestation of systemic lupus erythematosus. We report the case of a patient with non-responding SLS (neither to glucocorticoids nor immunosupresors), who showed remarkable improvement after the onset of treatment with rituximab. Although there is a little evidence, treatment with rituximab could be proposed in SLS when classical treatment fails. © 2013 Elsevier España, S.L.
Original languageEnglish
Pages (from-to)325-327
JournalReumatologia Clinica
Volume10
Issue number5
DOIs
Publication statusPublished - 1 Jan 2014

Keywords

  • Glucocorticoids
  • Rituximab
  • Shrinking lung syndrome
  • Systemic lupus erythematosus

Fingerprint

Dive into the research topics of 'Rituximab in the treatment of shrinking lung syndrome in systemic lupus erythematosus'. Together they form a unique fingerprint.

Cite this